搜尋





搜尋





市場行情
/
股票
/
rvmd
/

Revolution Medicines Inc

RVMD

添加自選

184.000USD

-4.070-2.16%

收盤 07-28 16:00（美東）報價延遲15分鐘

36.25B總市值

虧損本益比TTM

Revolution Medicines Inc

184.000

-4.070-2.16%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

RVMD 利潤表

您可以在這裡找到Revolution Medicines Inc的年度或季度收入報告，以深入了解Revolution Medicines Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

營業總收入

----

--0.00

----

-100.00%0.00

--0.00

-100.00%0.00

-95.16%742.00K

-100.00%0.00

-58.05%3.82M

-7.44%7.01M

62.05%15.33M

204.81%3.36M

4.81%9.12M

-25.20%7.58M

8.10%9.46M

-91.30%1.10M

-13.24%8.70M

-12.26%10.13M

-27.61%8.75M

1.24%12.66M

-18.37%10.03M

-12.30%11.55M

16.83%12.09M

--12.51M

--12.28M

--13.17M

--10.35M

營業收入

----

-100.00%0.00

--0.00

-100.00%0.00

-95.16%742.00K

-100.00%0.00

-58.05%3.82M

-7.44%7.01M

62.05%15.33M

204.81%3.36M

4.81%9.12M

-25.20%7.58M

8.10%9.46M

-91.30%1.10M

-13.24%8.70M

-12.26%10.13M

-27.61%8.75M

1.24%12.66M

-18.37%10.03M

-12.30%11.55M

16.83%12.09M

--12.51M

--12.28M

--13.17M

--10.35M

營業費用

84.92%445.22M

67.18%361.63M

79.42%315.27M

68.99%264.71M

70.92%240.76M

19.69%216.31M

42.57%175.71M

39.09%156.64M

71.42%140.86M

134.60%180.72M

54.27%123.25M

58.16%112.62M

25.40%82.17M

23.51%77.04M

47.22%79.89M

33.76%71.20M

37.87%65.53M

45.63%62.37M

34.94%54.26M

40.05%53.23M

45.67%47.53M

35.32%42.83M

54.28%40.21M

66.40%38.01M

38.24%32.63M

43.77%31.65M

--26.07M

--22.84M

--23.60M

--22.02M

研發費用

67.18%343.97M

56.80%294.94M

72.98%262.51M

66.11%224.13M

74.33%205.75M

26.68%188.10M

40.86%151.75M

37.71%134.93M

71.18%118.02M

124.54%148.48M

55.11%107.73M

60.62%97.98M

22.05%68.95M

23.19%66.13M

49.45%69.45M

32.80%61.00M

38.26%56.49M

45.06%53.68M

33.27%46.47M

39.55%45.94M

48.81%40.86M

34.62%37.01M

51.86%34.87M

63.63%32.92M

29.60%27.46M

51.20%27.49M

--22.96M

--20.12M

--21.19M

--18.18M

折舊攤銷及損耗

17.77%2.35M

16.31%2.37M

19.98%2.33M

5.97%2.06M

8.26%1.99M

26.01%2.04M

23.93%1.94M

27.51%1.94M

22.26%1.84M

12.07%1.61M

20.54%1.57M

23.72%1.52M

25.31%1.50M

32.81%1.44M

18.18%1.30M

11.91%1.23M

20.10%1.20M

8.50%1.08M

10.00%1.10M

13.64%1.10M

7.30%1.00M

15.61%1.00M

14.55%1.00M

14.69%968.00K

17.53%932.00K

25.18%865.00K

--873.00K

--844.00K

--793.00K

--691.00K

營業利潤

-84.92%-445.22M

-67.18%-361.63M

-79.42%-315.27M

-68.99%-264.71M

-70.92%-240.76M

-20.18%-216.31M

-42.57%-175.71M

-43.98%-156.64M

-87.42%-140.86M

-191.67%-179.98M

-61.04%-123.25M

-75.23%-108.80M

-29.70%-75.16M

-16.62%-61.71M

-43.96%-76.53M

-39.42%-62.09M

-54.96%-57.95M

-55.26%-52.91M

-92.96%-53.16M

-59.14%-44.53M

-77.39%-37.40M

-74.20%-34.08M

-103.19%-27.55M

-164.97%-27.98M

-102.01%-21.08M

-67.66%-19.56M

---13.56M

---10.56M

---10.44M

---11.67M

淨非營業利息收入（費用）

利息收入

-21.70%19.51M

0.32%21.29M

8.19%22.08M

4.27%22.40M

4.86%24.91M

11.85%21.23M

86.45%20.41M

104.66%21.49M

236.59%23.76M

273.78%18.98M

276.57%10.95M

1110.96%10.50M

2237.42%7.06M

2042.19%5.08M

1203.59%2.91M

267.37%867.00K

29.61%302.00K

-5.95%237.00K

-35.73%223.00K

-67.67%236.00K

-74.37%233.00K

-59.22%252.00K

-54.70%347.00K

55.32%730.00K

171.34%909.00K

70.25%618.00K

--766.00K

--470.00K

--335.00K

--363.00K

利息費用

--12.20M

--11.94M

--11.43M

----

--303.00K

----

--0.00

-100.00%0.00

-42.86%12.00K

-39.13%14.00K

-32.00%17.00K

-32.14%19.00K

-30.00%21.00K

-30.30%23.00K

--25.00K

--28.00K

--30.00K

--33.00K

特殊收入（費用）

-747.31%-15.79M

-5639.55%-12.63M

53.35%-592.00K

-340.06%-4.58M

120.72%2.44M

-291.30%-220.00K

---1.27M

--1.91M

--1.10M

--115.00K

----

--0.00

----

--0.00

其他非經營性收入（費用）

-1070.00%-117.00K

129.41%5.00K

-100.00%0.00

-5718.75%-899.00K

-11.11%-10.00K

---17.00K

--282.00K

--16.00K

---9.00K

----

稅前利潤

-112.64%-453.82M

-86.82%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-21.17%-195.32M

-39.17%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-184.64%-161.19M

-52.53%-112.30M

-60.56%-98.30M

-18.13%-68.10M

-7.51%-56.63M

-39.07%-73.63M

-38.20%-61.22M

-55.07%-57.65M

-55.65%-52.68M

-94.48%-52.94M

-62.43%-44.30M

-84.09%-37.18M

-78.41%-33.84M

-112.37%-27.22M

-169.52%-27.27M

-99.33%-20.19M

-67.29%-18.97M

---12.82M

---10.12M

---10.13M

---11.34M

所得稅

----

100.00%0.00

--0.00

----

-319.53%-753.00K

100.00%0.00

--0.00

378.86%343.00K

-1202.02%-3.87M

--0.00

---123.00K

---297.00K

--0.00

-100.00%0.00

--0.00

100.00%0.00

----

108.28%362.00K

--0.00

---58.00K

---675.00K

---4.37M

----

--0.00

----

除稅後利潤

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

-62.77%-44.30M

-90.46%-37.18M

-134.34%-34.20M

-112.37%-27.22M

-168.95%-27.21M

-92.67%-19.52M

-28.72%-14.60M

---12.82M

---10.12M

---10.13M

---11.34M

持續經營利潤

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

-62.77%-44.30M

-90.46%-37.18M

-134.34%-34.20M

-112.37%-27.22M

-168.95%-27.21M

-92.67%-19.52M

-28.72%-14.60M

---12.82M

---10.12M

---10.13M

---11.34M

歸属于母公司的淨利潤

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

-62.77%-44.30M

-71.02%-37.18M

-81.48%-34.20M

-59.51%-27.22M

-106.46%-27.21M

-69.74%-21.74M

-36.00%-18.85M

---17.07M

---13.18M

---12.81M

---13.86M

優先股派息

----

--0.00

----

--0.00

----

-100.00%0.00

-17.08%2.22M

68.76%4.25M

--4.25M

--3.06M

--2.68M

--2.52M

歸屬普通股東的淨利潤

-112.64%-453.82M

-87.54%-364.89M

-95.28%-305.21M

-85.98%-247.79M

-83.97%-213.42M

-20.45%-194.57M

-44.13%-156.29M

-35.54%-133.23M

-70.35%-116.00M

-185.87%-161.54M

-47.87%-108.43M

-60.56%-98.30M

-18.13%-68.10M

-7.27%-56.51M

-38.51%-73.33M

-38.20%-61.22M

-55.07%-57.65M

-54.01%-52.68M

-94.48%-52.94M

-62.77%-44.30M

-71.02%-37.18M

-81.48%-34.20M

-59.51%-27.22M

-106.46%-27.21M

-69.74%-21.74M

-36.00%-18.85M

---17.07M

---13.18M

---12.81M

---13.86M

基本每股收益

-101.96%-2.29

-67.95%-1.88

-72.18%-1.61

-62.86%-1.31

-61.08%-1.13

2.18%-1.12

5.64%-0.94

12.28%-0.81

1.93%-0.70

-80.33%-1.14

-14.65%-0.99

-11.58%-0.92

7.62%-0.72

11.27%-0.63

-20.26%-0.87

-36.56%-0.82

-47.24%-0.78

-38.53%-0.71

-71.62%-0.72

-30.29%-0.60

-43.29%-0.53

-61.25%-0.52

-30.04%-0.42

-107.34%-0.46

-69.74%-0.37

-21.94%-0.32

---0.32

---0.22

---0.26

稀釋每股收益

-101.96%-2.29

-67.95%-1.88

-72.18%-1.61

-62.86%-1.31

-61.08%-1.13

2.18%-1.12

5.64%-0.94

12.28%-0.81

1.93%-0.70

-80.33%-1.14

-14.65%-0.99

-11.58%-0.92

7.62%-0.72

11.27%-0.63

-20.26%-0.87

-36.56%-0.82

-47.24%-0.78

-38.53%-0.71

-71.62%-0.72

-30.29%-0.60

-43.29%-0.53

-61.25%-0.52

-30.04%-0.42

-107.34%-0.46

-69.74%-0.37

-21.94%-0.32

---0.32

---0.22

---0.26

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Revolution Medicines Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 RVMD 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Revolution Medicines Inc 全年的淨利潤是多少？



Revolution Medicines Inc 2025 財年淨利潤為 -1.13B。

Revolution Medicines Inc 上一季度的淨利潤是多少？



Revolution Medicines Inc 最近一個季度的淨利潤為 -453.82M。

Revolution Medicines Inc 年度營業利潤是多少？



Revolution Medicines Inc 2025 財年的營業利潤為 -1.18B。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。